Clinical Trial Update: 3T MRI to Predict TACE Response of HCC

View source ↗

Summary

This clinical trial update reports on using 3T magnetic resonance imaging to predict response to transarterial chemoembolization in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Carcinoma, Hepatocellular | Status: UNKNOWN